The aortic-aneurysm is a swelling & dilation the wall of blood-vessel, in general an artery, owing to weakness or degeneration, which develops in the segment of artery wall. Endovascular-aneurysm-repair or EVAR contains the conveying of implant in the aneurysm through small-groin incisions with X-rays to guide the graft into place. EVAR is an ideal treatment option for the aortic aneurysm considering to its advantages over the open surgery. Some of the other key advantages consist of shorter hospital stay, quick recovery time, enhanced patient outcomes, and no abdominal surgery. Therefore, such EVAR procedure is well known for the standard intervention associated to abdominal aortic aneurysm (AAA). Endovascular surgery is performed in the aorta using long, thin tubes known as catheters to place a stent that is wrapped in a fabric liner to reinforce the weak spots. EVAR additionally entails placing a stent graft into the aneurysm over the inguinal arteries the usage of x-ray guidance to position it properly. A stent is placed in an aneurysmal area of the aorta to provide permanent alternative channel for the blood flow within the patient’s vasculature, thereby further preventing the aneurysmal sac from the blood flow pressure and rupturing. A stent-graft also comprises a metal skeleton (stainless steel or nitinol), which is covered with an impermeable tissue (polytetrafluoroethylene or polyester) and is fixed under fluoroscopic control through the femoral arteries. The EVAR patients are suggested to undergo consistent follow-up imaging surveillance, particularly for patients wherever the secondary intervention would be considered.
Referring to the study, Global Evar Stent Grafts Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread). Some of the key companies operating in the global evar stents grafts market include Cardinal Health (Cordis), Medtronic, Terumo (Vascutek), Cook, Boston Scientific, Endologix, TriVascular, MicroPort Scientific Corporation and among others.
Based on types, evar stents grafts market can be segmented as Thoracic Aortic Stent Grafts and Abdominal Aortic Stent (AAA) Grafts. Thoracic aortic aneurysm is further sub-segmented as thoracoabdominal, ascending, descending and thoracic arch aortic aneurysm. In addition, based on application type, market can be segmented as Traumatic aortic injury treatment and Ruptured AAA treatment.
Increase in efforts for creating awareness about aneurysms, followed by growth in population and increase in acceptance of EVAR procedures worldwide are some major factors, which are responsible for growth of the evar stents grafts market. Apart from this, increase in acceptance of balloon angioplasty may impact the market. Moreover, rise in demand for minimally invasive procedures and surge in technological advancements in EVAR are leading opportunities for market.
Based on regional analysis, the North-America is a leading region in global evar stents grafts market owing to surge in demand for minimally invasive endovascular surgeries across the region. The Asia-Pacific and Europe regions are estimated to witness higher growth rate due to increase in healthcare awareness and facilities over the forecast period. It is projected that future of the global evar stents grafts market will be bright as a result of increase in number of people affected by obesity & diabetes during the forecast period.
For More Information, Click on the Link Below:-
Global Evar Stent Grafts Market
Related Reports:-
Global EVAR Stent Grafts Market Status and Future Forecast 2015-2025
Global EVAR Stent Grafts Market Analysis 2013-2018 and Forecast 2019-2024
Contact Us:-
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-9015378249
